FDA Inspection 1193220 — Cambrex Profarmaco Milano Srl
The FDA completed an inspection of Cambrex Profarmaco Milano Srl on Nov 11, 2022 in Paullo. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 11, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Paullo (Italy)